These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain. Monge S, Alejos B, Dronda F, Del Romero J, Iribarren JA, Pulido F, Rubio R, Miró JM, Gutierrez F, Del Amo J, CoRIS. HIV Med; 2013 May; 14(5):273-83. PubMed ID: 23171059 [Abstract] [Full Text] [Related]
5. [New diagnosis of HIV infection in children]. Guillén S, Prieto L, Jiménez de Ory S, González-Granado I, González-Tomé MI, Mellado MJ, de José M, Navarro ML, Beceiro J, Roa MÁ, Muñoz MÁ, Tomás Ramos J, en nombre de la Cohorte de Niños Infectados de la Comunidad de Madrid. Enferm Infecc Microbiol Clin; 2012 Mar; 30(3):131-6. PubMed ID: 22119095 [Abstract] [Full Text] [Related]
8. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London. Mohsen AH, Murad S, Easterbrook PJ. HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288 [Abstract] [Full Text] [Related]
14. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida. Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [Abstract] [Full Text] [Related]
16. Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. Thierfelder C, Weber R, Elzi L, Furrer H, Cavassini M, Calmy A, Bernasconi E, Gutmann C, Ledergerber B, Swiss HIV Cohort Study Group. HIV Med; 2012 Feb; 13(2):118-26. PubMed ID: 22107170 [Abstract] [Full Text] [Related]
17. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals. Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD, HepaI.Co.N.A. Study Group, Italian Cohort Naive for Antiretrovirals Study Group. Clin Infect Dis; 2005 Jun 15; 40(12):e101-9. PubMed ID: 15909251 [Abstract] [Full Text] [Related]
18. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors. Loebstein R, Mahagna R, Maor Y, Kurnik D, Elbaz E, Halkin H, Olchovsky D, Ezra D, Almog S. Isr Med Assoc J; 2008 Nov 15; 10(11):775-8. PubMed ID: 19070285 [Abstract] [Full Text] [Related]
19. [Patients with human immunodeficiency virus admitted to the emergency service of a general hospital]. Iglesias ML, Pedro-Botet J, Hernández E, Villalta R, Alvarez A, Gutiérrez J, Skaf E. Enferm Infecc Microbiol Clin; 1997 Nov 15; 15(9):468-72. PubMed ID: 9527371 [Abstract] [Full Text] [Related]
20. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT. AIDS; 2006 May 12; 20(8):1171-9. PubMed ID: 16691069 [Abstract] [Full Text] [Related] Page: [Next] [New Search]